Peer review reports
From: Bevacizumab dose adjustment to improve clinical outcomes of glioblastoma
Original Submission | ||
---|---|---|
22 Dec 2019 | Submitted | Original manuscript |
2 Jan 2020 | Reviewed | Reviewer Report |
12 Mar 2020 | Reviewed | Reviewer Report |
31 Mar 2020 | Reviewed | Reviewer Report |
24 Apr 2020 | Author responded | Author comments - Noemi García-Romero |
27 Apr 2020 | Reviewed | Reviewer Report |
27 Apr 2020 | Reviewed | Reviewer Report |
28 Apr 2020 | Author responded | Author comments - Noemi García-Romero |
Resubmission - Version 2 | ||
24 Apr 2020 | Submitted | Manuscript version 2 |
Publishing | ||
29 Apr 2020 | Editorially accepted | |
22 Jun 2020 | Article published | 10.1186/s12916-020-01610-0 |